Denmark · Delayed Price · Currency is DKK BioMar Group Statistics
Total Valuation
BioMar Group has a market cap or net worth of DKK 10.85 billion. The enterprise value is 14.49 billion.
| Market Cap | 10.85B |
| Enterprise Value | 14.49B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioMar Group has 100.50 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 100.50M |
| Shares Outstanding | 100.50M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.02 and the forward PE ratio is 12.74.
| PE Ratio | 0.02 |
| Forward PE | 12.74 |
| PS Ratio | 0.66 |
| PB Ratio | 4.23 |
| P/TBV Ratio | 8.73 |
| P/FCF Ratio | 9.93 |
| P/OCF Ratio | 8.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.46, with an EV/FCF ratio of 13.26.
| EV / Earnings | 20.41 |
| EV / Sales | 0.89 |
| EV / EBITDA | 7.46 |
| EV / EBIT | 12.48 |
| EV / FCF | 13.26 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.68.
| Current Ratio | 0.82 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.68 |
| Debt / EBITDA | 2.28 |
| Debt / FCF | 3.95 |
| Interest Coverage | 5.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.38% |
| Return on Capital Employed (ROCE) | 36.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.38M |
| Profits Per Employee | 407,577 |
| Employee Count | 1,742 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioMar Group has paid 264.00 million in taxes.
| Income Tax | 264.00M |
| Effective Tax Rate | 26.22% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 396,338 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMar Group had revenue of DKK 16.34 billion and earned 710.00 million in profits. Earnings per share was 7,088.30.
| Revenue | 16.34B |
| Gross Profit | 3.67B |
| Operating Income | 1.11B |
| Pretax Income | 1.01B |
| Net Income | 710.00M |
| EBITDA | 1.74B |
| EBIT | 1.11B |
| Earnings Per Share (EPS) | 7,088.30 |
Balance Sheet
The company has 683.00 million in cash and 4.32 billion in debt, with a net cash position of -3.63 billion or -36.16 per share.
| Cash & Cash Equivalents | 683.00M |
| Total Debt | 4.32B |
| Net Cash | -3.63B |
| Net Cash Per Share | -36.16 |
| Equity (Book Value) | 2.56B |
| Book Value Per Share | 25,630.00 |
| Working Capital | -1.48B |
Cash Flow
In the last 12 months, operating cash flow was 1.31 billion and capital expenditures -216.00 million, giving a free cash flow of 1.09 billion.
| Operating Cash Flow | 1.31B |
| Capital Expenditures | -216.00M |
| Depreciation & Amortization | 632.00M |
| Net Borrowing | 1.34B |
| Free Cash Flow | 1.09B |
| FCF Per Share | 10.88 |
Margins
Gross margin is 22.45%, with operating and profit margins of 6.78% and 4.35%.
| Gross Margin | 22.45% |
| Operating Margin | 6.78% |
| Pretax Margin | 6.16% |
| Profit Margin | 4.35% |
| EBITDA Margin | 10.65% |
| EBIT Margin | 6.78% |
| FCF Margin | 6.69% |
Dividends & Yields
BioMar Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 220.99% |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | 6.54% |
| FCF Yield | 10.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioMar Group has an Altman Z-Score of 1.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 4 |